Cellectis S.A.
CMVLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $35 | $17 | $11 | $13 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $0 |
| Gross Profit | $33 | $14 | $9 | $13 |
| % Margin | 93.3% | 85.5% | 81.1% | 100% |
| R&D Expenses | $24 | $23 | $22 | $15 |
| G&A Expenses | $2 | $2 | $2 | $3 |
| SG&A Expenses | $2 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$2 | -$1 | -$1 | $5 |
| Operating Expenses | $25 | $24 | $23 | $23 |
| Operating Income | $8 | -$10 | -$14 | -$11 |
| % Margin | 22.9% | -57.3% | -133.1% | -84% |
| Other Income/Exp. Net | -$7 | -$14 | -$4 | $17 |
| Pre-Tax Income | $1 | -$24 | -$18 | $6 |
| Tax Expense | $0 | -$0 | $0 | $1 |
| Net Income | $1 | -$24 | -$18 | $6 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS | 0.006 | -0.25 | -0.18 | 0.059 |
| % Growth | 102.4% | -38.9% | -404.1% | – |
| EPS Diluted | 0.006 | -0.25 | -0.18 | 0.058 |
| Weighted Avg Shares Out | 100 | 100 | 100 | 100 |
| Weighted Avg Shares Out Dil | 100 | 100 | 100 | 100 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $3 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $5 | $5 | $5 | $6 |
| EBITDA | $8 | -$17 | -$11 | $12 |
| % Margin | 21.9% | -99.6% | -105.9% | 96.9% |